Literature DB >> 12208315

The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor.

Yasuko Nagoshi1, Kenji Kuwasako, Kaoru Ito, Tomohiko Uemura, Johji Kato, Kazuo Kitamura, Tanenao Eto.   

Abstract

The receptor activity-modifying protein (RAMP)/calcitonin receptor-like (CRL) receptor heterodimer is thought to function as a receptor for either a calcitonin gene-related peptide (CGRP) (CRL receptor/RAMP1) or adrenomedullin (CRL receptor/RAMP2 or -3), depending on the RAMP isoform present. We examined the receptor specificity of adrenomedullin-induced increases in cAMP in human embryonic kidney (HEK)293 cells coexpressing human CRL receptor and human RAMP1 or RAMP2. In cells expressing CRL receptor/RAMP1, adrenomedulin-induced increases in cAMP were comparable to those induced by alpha-CGRP, and the CGRP receptor antagonist alpha-CGRP-(8-37), but not the adrenomedullin receptor antagonist adrenomedullin-(22-52), blocked the adrenomedullin-evoked responses. Cells expressing CRL receptor/RAMP2 responded more selectively to adrenomedullin; in this case, the effect was blocked by adrenomedullin-(22-52) but not by alpha-CGRP-(8-37). Real-time quantitative polymerase chain reaction confirmed that cotransfection of CRL receptor and RAMP1 had no effect on the endogenous expression of RAMP2. Thus, CRL receptor/RAMP1 likely functions as an adrenomedullin receptor as well as a CGRP receptor, which may explain why many of the actions of adrenomedullin are potently antagonized by alpha-CGRP-(8-37).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208315     DOI: 10.1016/s0014-2999(02)02184-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors.

Authors:  Debbie L Hay; Alex C Conner; Stephen G Howitt; David M Smith; David R Poyner
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

2.  Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture.

Authors:  Mohammad A Takhshid; David R Poyner; Jean-Guy Chabot; Alain Fournier; Weiya Ma; Wen-Hua Zheng; Ali A Owji; Remi Quirion
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

3.  CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS.

Authors:  D L Hay; S G Howitt; A C Conner; M Schindler; D M Smith; D R Poyner
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

4.  Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice.

Authors:  Kazutake Tsujikawa; Katsutoshi Yayama; Tamon Hayashi; Hiroaki Matsushita; Taijiro Yamaguchi; Tomomi Shigeno; Yusuke Ogitani; Megumi Hirayama; Tetsuya Kato; So-ichiro Fukada; Shingo Takatori; Hiromu Kawasaki; Hiroshi Okamoto; Masahito Ikawa; Masaru Okabe; Hiroshi Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-08       Impact factor: 11.205

5.  Increased adrenomedullin immunoreactivity and mRNA expression in coronary plaques obtained from patients with unstable angina.

Authors:  T Ishikawa; K Hatakeyama; T Imamura; K Ito; S Hara; H Date; Y Shibata; Y Hikichi; Y Asada; T Eto
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

6.  RNA SEQ Analysis Indicates that the AE3 Cl-/HCO3- Exchanger Contributes to Active Transport-Mediated CO2 Disposal in Heart.

Authors:  Kanimozhi Vairamani; Hong-Sheng Wang; Mario Medvedovic; John N Lorenz; Gary E Shull
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

7.  The Role of Adrenomedullin in Cardiovascular Response to Exercise - A Review.

Authors:  Krzysztof Krzeminski
Journal:  J Hum Kinet       Date:  2016-10-14       Impact factor: 2.193

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.